Position statement: Utility, limitations, and pitfalls in measuring testosterone: an Endocrine Society position statement
about
sameAs
Endocrinology and physiology of pseudocyesisIdentification of SOX3 as an XX male sex reversal gene in mice and humansA practical guide to diagnosis, management and treatment of testosterone deficiency for Canadian physiciansSex and gender issues in competitive sports: investigation of a historical case leads to a new viewpointDiagnostic criteria for polycystic ovary syndrome: pitfalls and controversiesPrevalence of hyperandrogenemia in the polycystic ovary syndrome diagnosed by the National Institutes of Health 1990 criteriaThe benefits and risks of testosterone replacement therapy: a reviewA Positive Affective Neuroendocrinology Approach to Reward and Behavioral DysregulationA review of the relationships between endogenous sex steroids and incident ischemic stroke and coronary heart disease eventsMeasurement of androgen and estrogen concentrations in cord blood: accuracy, biological interpretation, and applications to understanding human behavioral developmentTestosterone concentrations, using different assays, in different types of ovarian insufficiency: a systematic review and meta-analysisEndogenous sex hormones, metabolic syndrome, and diabetes in men and womenAndropause: Current conceptsSex differences in contaminant concentrations of fish: a synthesisThe effects of testosterone and insulin-like growth factor 1 on motor system form and functionScientific Statement on the Diagnostic Criteria, Epidemiology, Pathophysiology, and Molecular Genetics of Polycystic Ovary Syndrome.The effect of combined oral contraception on testosterone levels in healthy women: a systematic review and meta-analysisPremature decline of serum total testosterone in HIV-infected men in the HAART-eraTestosterone is associated with erectile dysfunction: a cross-sectional study in Chinese menHarnessing expression data to identify novel candidate genes in polycystic ovary syndromeCLINICAL PRACTICE. Polycystic Ovary Syndrome.Predicting low testosterone in aging men: a systematic review.Persistent apparent pancreatic β-cell defects in premenarchal PCOS relatives.Total testosterone assays in women with polycystic ovary syndrome: precision and correlation with hirsutism.Testosterone, sex hormone-binding globulin and the metabolic syndrome in men: an individual participant data meta-analysis of observational studies.Cut-off levels for hyperandrogenemia among Samoan women: An improved methodology for deriving normative data in an obese populationChallenges in Testosterone Measurement, Data Interpretation, and Methodological Appraisal of Interventional Trials.Effect of high-dose isoflavones on cognition, quality of life, androgens, and lipoprotein in post-menopausal women.Insulin resistance and the polycystic ovary syndrome revisited: an update on mechanisms and implications.Diagnosis and treatment of polycystic ovary syndrome: an Endocrine Society clinical practice guidelineTestosterone deficiency in adults and corresponding treatment patterns across the globe.Acupuncture for polycystic ovarian syndrome: A systematic review and meta-analysis.Tandem mass spectrometry as a novel tool for elucidating pituitary-thyroid relationships.Validity of estimating non-sex hormone-binding globulin bound testosterone and oestradiol from total hormone measurements in boys and girls.Associations of Maternal and Infant Testosterone and Cortisol Levels With Maternal Depressive Symptoms and Infant Socioemotional Problems.Effects of perinatal testosterone on infant health, mother-infant interactions, and infant development.Association between testosterone, estradiol and sex hormone binding globulin levels in men with type 1 diabetes with nephropathy.Digit ratios do not serve as anatomical evidence of prenatal androgen exposure in clinical phenotypes of polycystic ovary syndromeFree testosterone levels are associated with mobility limitation and physical performance in community-dwelling men: the Framingham Offspring StudySpecificity and predictive value of circulating testosterone assessed by tandem mass spectrometry for the diagnosis of polycystic ovary syndrome by the National Institutes of Health 1990 criteria
P2860
Q21245565-2D658452-018E-4FE7-B8F5-62552F004A52Q24320278-323DC951-835E-48FE-884D-73635E724BA4Q24602168-2574885A-4098-4081-9BE0-E9F6D12C8846Q24604042-5DE22B12-9B6E-4211-986A-277C07024343Q24626844-7C311D8B-A8B4-463B-A72A-313F4902A90FQ24632310-72FD05DB-6BAE-45A5-BB85-0DE4AADFE481Q24658011-8072B684-FE51-41CE-9817-5E50201D512CQ26802127-AA6CAEE5-D51C-4C1D-BB7F-EE4827D97E3EQ26822460-9AA74DFC-B4F0-4E43-83D8-95F995EF6166Q26825356-B6A883BB-5E56-4163-9AD6-E5EAAD67226DQ27002477-97A2AF79-8DEF-44B8-B2B9-1C1BA9019886Q27023901-04CFC2A1-EC22-45D9-88E5-D8E788E7A3D6Q27024886-50FE5C58-577E-48D3-8401-E8664539E871Q28072784-19D4D1E6-846B-46ED-9BBE-59A7AE14B323Q28083798-55DBBD00-764C-4DB1-8997-7C21A7660CB1Q28390200-A6F836A9-4945-4C64-9235-FD46493F669BQ28392020-FB37A670-1BBC-4A89-8264-66D9045E9EFCQ28478337-192103AA-1AD8-481A-AF05-0AD24570FD2EQ28480582-49CCC9C1-3C58-44C4-9AD1-C1D02C9E6CA6Q28744513-C4C66E81-2E47-4A4C-B9E4-7EB662E494D5Q29248890-F8A1B413-83BA-4F50-9326-9053B18944AFQ30249472-E1575DD3-9958-4A3B-8507-F1DB38068796Q30370657-F3894499-A610-49A7-A1C0-F868F1017A12Q30429467-34B144B0-5EDB-4184-A5DE-3B5BAFFB6991Q30836337-0D56561B-B17F-4F9D-91EF-30034729D106Q31048633-0F28FB68-85B0-462C-9076-17DBBB33FCC2Q31099075-1EF2A52B-6278-40D9-ACA7-29B93DF93E2CQ33438267-54E4635C-2CA4-48C2-A5AB-1A110AD4841FQ33569169-3B766F67-68DC-4A52-B0D2-DC13A1A4136CQ33587845-08DFD3B6-D0C5-4306-A5CC-6AA982183C14Q33650762-32ED3A3D-06E9-408E-914F-A0D451D3750EQ33686328-4B5DB039-EB2E-4634-9B21-33C2AE4EE872Q33801438-ED21248C-2026-4146-B25D-B950A683921CQ33824739-ED9B79AE-E0F1-410B-8AA0-CF2E3624C149Q33880230-609D2E4E-AD3A-4376-A0E2-FF6B1DDDCFD3Q33894369-FE0842A1-C189-466E-A245-8B3FC1872D44Q33940015-534799D2-DB05-4AD3-9EBD-72403D3AFE88Q33948903-FB1D0028-3F96-47A3-9121-FF81DC93E950Q33984860-4F5ABA22-1870-41F7-AEF3-CE114BA26576Q34009160-D6CB4561-BB30-4A84-990D-35B4A5128766
P2860
Position statement: Utility, limitations, and pitfalls in measuring testosterone: an Endocrine Society position statement
description
2007 nî lūn-bûn
@nan
2007 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Position statement: Utility, l ...... ine Society position statement
@ast
Position statement: Utility, l ...... ine Society position statement
@en
Position statement: Utility, l ...... ine Society position statement
@nl
type
label
Position statement: Utility, l ...... ine Society position statement
@ast
Position statement: Utility, l ...... ine Society position statement
@en
Position statement: Utility, l ...... ine Society position statement
@nl
altLabel
Utility, Limitations, and Pitf ...... ine Society Position Statement
@en
prefLabel
Position statement: Utility, l ...... ine Society position statement
@ast
Position statement: Utility, l ...... ine Society position statement
@en
Position statement: Utility, l ...... ine Society position statement
@nl
P2093
P3181
P356
P1476
Position statement: Utility, l ...... ine Society position statement
@en
Utility, Limitations, and Pitf ...... ine Society Position Statement
@en
P2093
Hershel Raff
Patrick M Sluss
Patrick M. Sluss
Richard J Auchus
Richard J. Auchus
William Rosner
P3181
P356
10.1210/JC.2006-1864
P407
P577
2007-02-01T00:00:00Z